50 mg

( DrugBank: - / KEGG DRUG: - )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
97	潰瘍性大腸炎	281

97. 潰瘍性大腸炎

臨床試験数 : 2,630 / 薬物数 : 1,459 - (DrugBank : 265) / 標的遺伝子数 : 144 - 標的パスウェイ数 : 202

trials per page:

Showing 1 to 10 of 281 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05535946 (ClinicalTrials.gov)	January 16, 2023	7/9/2022	ABTECT - Maintenance	A Randomized, Double-blind, Multicenter Phase III Study to Evaluate the Long-term Efficacy and Safet ...	Ulcerative Colitis	Drug: ABX464;Drug: Placebo	Abivax S.A.	NULL	Recruiting	16 Years	N/A	All	1050	Phase 3	United States
2	EUCTR2021-005528-39-NL (EUCTR)	14/12/2022	12/09/2022	Efficacy and Safety of Combination Therapy with Guselkumab and Golimumab in Participants with Modera ...	A Phase 2b Randomized, Double-blind, Active-and Placebo-controlled, Parallel-group, Multicenter Stud ...	Moderately to Severely Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classification code ...	Product Name: JNJ-78934804 INN or Proposed INN: Guselkumab Other descriptive name: Guselkumab INN or Pr ...	Janssen-Cilag International NV	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	550	Phase 2	Portugal;Taiwan;Hong Kong;Slovakia;Greece;Ukraine;Chile;Italy;India;France;Jordan;Denmark;Latvia;Kor ...
3	NCT05558761 (ClinicalTrials.gov)	October 10, 2022	25/9/2022	Pentoxifylline as Adjunctive Therapy in Patients With Ulcerative Colitis	Clinical Study to Evaluate the Possible Efficacy of Pentoxifylline in Patients With Ulcerative Colit ...	Inflammatory Bowel Diseases	Drug: Pentoxifylline 400 MG	Tanta University	NULL	Recruiting	18 Years	75 Years	All	50	Phase 2	Egypt
4	EUCTR2021-002549-13-PT (EUCTR)	02/08/2022	27/10/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals AB	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Serbia;United States;Portugal;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
5	EUCTR2021-003702-42-ES (EUCTR)	17/05/2022	12/05/2022	A Phase 3 Placebo-controlled Efficacy and Safety Study with Ritlecitinib (PF-06651600) in Adults wit ...	AN INTERVENTIONAL PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO CONTROLLED, PARALLEL GROUP STUDY OF THE ...	Moderate to Severe Ulcerative Colitis (UC) MedDRA version: 20.1;Level: LLT;Classification code 10045 ...	Product Name: Ritlecitinib Product Code: PF-06651600 INN or Proposed INN: PF-06651600 Other descriptive ...	Pfizer Inc.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	432	Phase 3	Serbia;United States;Taiwan;Slovakia;Greece;Spain;Ukraine;Russian Federation;Israel;Switzerland;Ital ...
6	EUCTR2021-002549-13-DK (EUCTR)	21/04/2022	24/01/2022	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
7	EUCTR2021-002549-13-AT (EUCTR)	31/03/2022	25/10/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy;France;Australia;Denmark;South Afric ...
8	EUCTR2021-002549-13-NO (EUCTR)	07/03/2022	24/11/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	United States;Portugal;Serbia;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
9	EUCTR2021-002549-13-HR (EUCTR)	24/02/2022	28/02/2022	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...
10	EUCTR2021-002549-13-LT (EUCTR)	02/12/2021	06/09/2021	A Phase III Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance ...	A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and S ...	Moderate to Severe left-sided Active Ulcerative Colitis MedDRA version: 20.1;Level: LLT;Classificati ...	Product Name: Cobitolimod INN or Proposed INN: COBITOLIMOD Product Name: Cobitolimod INN or Proposed IN ...	InDex Pharmaceuticals	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	440	Phase 3	Portugal;Serbia;United States;Taiwan;Slovakia;Spain;Ukraine;Russian Federation;Israel;Colombia;Italy ...

First Previous1 2 3 4 5…29Next Last